Do you already have the antibodies for the Covid Virus.
Research is currently being carried out may give you the edge against the virus.
Did you have the Tuberculosis Vaccine when you were a child. if so, you already might have the antibodies needed to protect yourself.
The Telegraph, The Irish Times, Euronews and Medrxiv have all reported on this.
The Telegraph - BCG jabs mean you are six times less likely to get coronavirus, study finds New research suggests that countries with widespread tuberculosis vaccination programmes have much lower rate of Coronavirus death rates are almost six times lower in countries with a widespread vaccination programme involving the Bacillus Calmette-Guérin (BCG) jab, a new study has found.The BCG vaccine gives immunity to tuberculosis, but mass vaccination was dropped in the UK in 2005 when rates of the lung infection dropped.Yet US-based experts now think the vaccine could improve immune systems and protect people from infection. New research, which is yet to be peer reviewed, suggests that countries with widespread BCG vaccination programmes have much lower rates of the coronavirus than nations without.
A study indicating that the BCG vaccine for tuberculosis could help to protect against Covid-19 is “a potential game-changer” in global efforts to curb the pandemic, according to a leading immunologist.
Taken from euronews Why has Spain had so many deaths from the coronavirus pandemic while Portugal’s death toll have been so low?Such a disparity in numbers within the Iberian peninsula is mysterious, but it could in part be explained by the two countries’ different use of a vaccine. Not a vaccine against COVID-19, the disease caused by the novel coronavirus – no such vaccine exists yet, rather it is the decades-old tuberculosis vaccine that seems to offer an explanation.
COVID-19 has spread to most countries in the world. Puzzlingly, the impact of the disease is different in different countries. These differences are attributed to differences in cultural norms, mitigation efforts, and health infrastructure. Here we propose that national differences in COVID-19 impact could be partially explained by the different national policies respect to Bacillus Calmette-Guerin (BCG) childhood vaccination. BCG vaccination has been reported to offer broad protection to respiratory infections. We compared large number of countries BCG vaccination policies with the morbidity and mortality for COVID-19. We found that countries without universal policies of BCG vaccination (Italy, Nederland, USA) have been more severely affected compared to countries with universal and long-standing BCG policies. Countries that have a late start of universal BCG policy (Iran, 1984) had high mortality, consistent with the idea that BCG protects the vaccinated elderly population. We also found that BCG vaccination also reduced the number of reported COVID-19 cases in a country. The combination of reduced morbidity and mortality makes BCG vaccination a potential new tool in the fight against COVID-19